News | Interventional Radiology | February 18, 2019

FDA Clears Mirada Medical's Simplicit90y Dosimetry Software

Interventional radiology software helps improve dose calculation and treatment planning for Y90 transarterial radioembolization

FDA Clears Mirada Medical's Simplicit90y Dosimetry Software

February 18, 2019 — Mirada Medical Ltd announced U.S. Food and Drug Administration (FDA) 510(k) clearance for Simplicit90Y. Designed in collaboration with BTG to facilitate personalized treatment for patients with liver cancer, Simplicit90Y is an easy-to-use dosimetry software developed for accelerating dosimetry planning and improving Y90 transarterial radioembolization (TARE) workflow.

Watch the VIDEO: Y90 Embolization of Liver Cancer at Henry Ford Hospital

Simplicit90Y provides digital processing, review and reporting of medical images, including planar scans (static, whole body) and tomographic scans acquired by gamma cameras or positron emission tomography (PET) scanners. The software is intended for use by interventional radiologists or nuclear medicine physicians, with unique options for data display, quality control, image manipulation and quantification analysis. Together, these features allow for more standardized and reproducible dosimetry planning and post-treatment validation, and the ability to personalize the treatment of each patient.

BTG will be at The Society of Interventional Radiology (SIR) 2019 congress, March 23-28 in Austin, Texas.

The FDA 510(k) clearance follows Simplicit90Y’s CE Mark certification and approval for use in Canada.

For more information: www.mirada-medical.com

Related Content

(a) A schematic of cycloidal computed tomography (not to scale, seen from top); by adding an array of beam stops in front of the detector, the setup is transformed into an edge-illumination x-ray phase-contrast imaging device. (b) A sinogram sampling grid for a rotation-only scheme. (c) A sinogram sampling grid for a cycloidal scheme. The grids are shown for one mask period and a subset of rotation angles; the combination of empty and filled circles shows the grids that would be achieved through fine latera

(a) A schematic of cycloidal computed tomography (not to scale, seen from top); by adding an array of beam stops in front of the detector, the setup is transformed into an edge-illumination x-ray phase-contrast imaging device. (b) A sinogram sampling grid for a rotation-only scheme. (c) A sinogram sampling grid for a cycloidal scheme. The grids are shown for one mask period and a subset of rotation angles; the combination of empty and filled circles shows the grids that would be achieved through fine lateral sampling (requiring dithering); the filled circles show the data that are sampled without dithering.

News | Computed Tomography (CT) | July 24, 2020
July 24, 2020 — A computed tomography (CT) sca
The radiology industry is saddened to learn of the passing of another leader to COVID-19. Franklin Wilfred Sequeira, M.D., 72, of Cicero, Ind., passed away June 1, 2020. He was just short of celebrating his 40th year working with Radiology of Indiana as an interventional radiologist, never missing a day of work.

Franklin Wilfred Sequeira, M.D.

News | Coronavirus (COVID-19) | June 13, 2020
June 13, 2020 — The r
Chief among the myriad practical updates to minimize risks for patients and imaging personnel alike is a tiered approach for delaying both outpatient and inpatient cross-sectional interventional procedures

For procedural delays that will not adversely affect patient outcome, Fananapazir and colleagues proposed the following tiered approach for both outpatient and inpatient scenarios: urgent procedures, procedures that should be performed within 2 weeks, procedures that should be performed within 2 months, and procedures that can safely be delayed 2 or 6 months. Courtesy of American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | June 05, 2020
June 5, 2020 — An...
#gadolinium Guerbet announced that it received U.S. Food and Drug Administration (FDA) approval to manufacture Dotarem (gadoterate meglumine) injection at its Raleigh, N.C., facility
News | Interventional Radiology | April 21, 2020
April 21, 2020 — Guerbet announced that it received U.S.
“Everybody cares about radiation dose, but the most sensitive to radiation are children, because they’re growing.”  —Richard Towbin, M.D., Chief of Radiology, Phoenix Children’s Hospital

“Everybody cares about radiation dose, but the most sensitive to radiation are children, because they’re growing.”
—Richard Towbin, M.D., Chief of Radiology, Phoenix Children’s Hospital

Sponsored Content | Case Study | Radiation Dose Management | April 09, 2020
Medical imaging plays an increasing role in the accurate diagnosis and treatment of numerous medical conditions.
Rising concerns over radiation overexposure teamed with a growing focus on improving the quality of patient care are two key drivers of today’s radiation dose management market. 

Rising concerns over radiation overexposure teamed with a growing focus on improving the quality of patient care are two key drivers of today’s radiation dose management market. 

Feature | Radiation Dose Management | April 02, 2020 | By Melinda Taschetta-Millane
Rising concerns over...
SIR President Laura Findeiss, M.D., FSIR

SIR President Laura Findeiss, M.D., FSIR

News | Interventional Radiology | February 09, 2020
February 9, 2020 — For some patients, kidney cancer can be effectively treated without surgery, according to the...
DSA image obtained approximately 24 hours after 1 mg/h IA tPA infusion, 500 U/h heparin via peripheral IV, and daily oral aspirin (81 mg) shows improved perfusion of digital arteries, albeit with suboptimal vascular blush of distal second and third phalanges

DSA image obtained approximately 24 hours after 1 mg/h IA tPA infusion, 500 U/h heparin via peripheral IV, and daily oral aspirin (81 mg) shows improved perfusion of digital arteries, albeit with suboptimal vascular blush of distal second and third phalanges. Photo courtesy of ARRS

News | Interventional Radiology | February 07, 2020
February 7, 2020 — An ahead-of-print...